Also: All the news and watercooler chat from Fortune.
Studies evaluating the oral JAK inhibitor in adults and adolescents with non-segmental vitiligo are submitted for approval of the expanded indication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results